Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
This is a open-label, prospective study comparing intravenous (IV) iron supplementation to
standard care in anemic patents undergoing peritoneal dialysis.
Phase:
Phase 3
Details
Lead Sponsor:
American Regent, Inc. Luitpold Pharmaceuticals
Treatments:
Epoetin Alfa Ferric Compounds Ferric Oxide, Saccharated Iron